Evidence map›Paper›PMID 37777256›Full record

ArticleJournal of neurointerventional surgery2024

Comparison of Thrombolysis In Cerebral Infarction (TICI) 2b and TICI 3 reperfusion in endovascular therapy for large ischemic anterior circulation strokes.

Laurens Winkelmeier, Tobias D Faizy, Caspar Brekenfeld, Christian Heitkamp, Gabriel Broocks, Matthias Bechstein, Paul Steffen, Maximilian Schell, Susanne Gellissen, Helge Kniep and 4 more

Registry-linked trialAbstract readMulticenter StudyComparative Study
In one paragraph

Article in Journal of neurointerventional surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03356392 (German Stroke Registry - Endovascular Treatment), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03356392 recruitingnot on this map

German Stroke Registry - Endovascular Treatment

Typeobservational_patient_registrySponsorUniversitätsklinikum Hamburg-EppendorfRan2015 to 2027Enrolled10,000ConditionsAcute Ischemic StrokeArmstelephone call d90
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Effects of reperfusion grade and reperfusion strategy on the clinical outcome: Insights from ESCAPE-NA1 trial.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Laurens WinkelmeierDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany l.winkelmeier@uke.de.ORCID http://orcid.org/0000-0002-9103-5983
Tobias D FaizyDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-1631-2020
Caspar BrekenfeldDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Christian HeitkampDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-8988-0918
Gabriel BroocksDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-7575-9850
Matthias BechsteinDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5652-7499
Paul SteffenDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Maximilian SchellDepartment of Neurology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Susanne GellissenDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Helge KniepDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5258-2370
Goetz ThomallaDepartment of Neurology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Jens FiehlerDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-8533-7478
Fabian FlottmannDepartment of Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-8358-8089
German Stroke Registry – Endovascular Treatment (GSR)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLandmark thrombectomy trials have provided evidence that selected patients with large ischemic stroke benefit from successful endovascular therapy, commonly defined as incomplete (modified Thrombolysis In Cerebral Infarction (mTICI) 2b) or complete reperfusion (mTICI 3). We aimed to investigate whether mTICI 3 improves functional outcomes compared with mTICI 2b in large ischemic strokes.

methodsThis retrospective multicenter cohort study was conducted to compare mTICI 2b versus mTICI 3 in large ischemic strokes in the anterior circulation. Patients enrolled in the German Stroke Registry between 2015-2021 were analyzed. Large ischemic stroke was defined as an Alberta Stroke Program Early CT Score (ASPECTS) of 3-5. Patients were matched by final mTICI grade using propensity score matching. Primary outcome was the 90-day modified Rankin Scale (mRS) score.

resultsAfter matching, 226 patients were included. Baseline and imaging characteristics were balanced between mTICI 2b and mTICI 3 patients. There was no shift on the mRS favoring mTICI 3 compared with mTICI 2b in large ischemic strokes (adjusted common odds ratio (acOR) 1.12, 95% confidence interval (95% CI) 0.64 to 1.94, P=0.70). The rate of symptomatic intracranial hemorrhage was higher in mTICI 2b than in mTICI 3 patients (12.6% vs 4.5%, P=0.03). Mortality at 90 days did not differ between mTICI 3 and mTICI 2b (33.6% vs 37.2%; adjusted OR 0.69, 95% CI 0.33 to 1.45, P=0.33).

conclusionsIn endovascular therapy for large ischemic strokes, mTICI 3 was not associated with better 90-day functional outcomes compared with mTICI 2b. This study suggests that mTICI 2b might be warranted as the final angiographic result, questioning the benefit/risk ratio of additional maneuvers to seek for mTICI 3 in large ischemic strokes. TRIAL REGISTRATION NUMBER: NCT03356392.

Indexed as

Endovascular ProceduresIschemic StrokeThrombolytic TherapyAgedAged, 80 and overCerebral InfarctionCohort StudiesFemaleHumansMaleMiddle AgedRegistriesReperfusionRetrospective StudiesThrombectomyTreatment Outcomeangiographybraininterventionstrokethrombectomy

Identifiers

PMID37777256
PMCPMC11503081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.